Table 2.
Group A (bupivacaine)(n=54) | Group B (placebo)(n=52) | p value | ||||
---|---|---|---|---|---|---|
Median | Range | Median | Range | |||
Primary endpoints | ||||||
VAS | 0 (immediately after awaking) | 0 | 0–7 | 1 | 0–9 | 0.077 |
1st post-operative hour | 2 | 0–6 | 3 | 0–8 | 0.126 | |
2nd post-operative hour | 1 | 0–6 | 2 | 0–9 | 0.09 | |
3rd post-operative hour | 0 | 0–8 | 1 | 0–6 | 0.105 | |
4th post-operative hour | 0 | 0–6 | 1 | 0–6 | 0.004 | |
8th post-operative hour | 0 | 0–8 | 0 | 0–8 | 0.193 | |
12th post-operative hour | 0 | 0–4 | 0 | 0–9 | 0.02 | |
16th post-operative hour | 0 | 0–5 | 0 | 0–6 | 0.088 | |
20th post-operative hour | 0 | 0–5 | 0 | 0–4 | 0.299 | |
24th post-operative hour | 0 | 0–8 | 1 | 0–4 | 0.352 | |
36th post-operative hour | 0 | 0–8 | 0 | 0–4 | 0.095 | |
48th post-operative hour | 0 | 0–7 | 0 | 0–6 | 0.499 | |
Secondary endpoints | ||||||
VAS | 0–4th post-operative hours | 5 | 0–33 | 9.5 | 0–30 | 0.016 |
4–12th post-operative hours | 1 | 0–15 | 2 | 0–16 | 0.011 | |
12–24th post-operative hours | 1 | 0–18 | 3 | 0–15 | 0.106 | |
24–48th post-operative hours | 3 | 0–23 | 5 | 0–20 | 0.997 | |
0–12th post-operative hours | 5.5 | 0–42 | 11 | 0–37 | 0.027 | |
0–48th post-operative hours | 9 | 0–61 | 13 | 0–50 | 0.076 | |
Intraoperative fentanyl consumption [mg] | 0.4 | 0.2–0.7 | 0.4 | 0.25–0.9 | 0.011 | |
PCA-MF consumption during 1st post-operative hour | 0 | 0–4 | 0 | 0–14 | 0.479 | |
PCA-MF consumption during first 4 post-operative hours | 2 | 0–24 | 2 | 0–24 | 0.517 | |
PCA-MF consumption during first 12 post-operative hours | 2 | 0–26 | 4 | 0–24 | 0.099 | |
PCA-MF consumption from 1st till 4th post-operative hour | 2 | 0–24 | 2 | 0–26 | 0.519 | |
PCA-MF consumption from 4th till 12th post-operative hour | 0 | 0–12 | 2 | 0–9 | 0.02 |
MF – morphine; VAS – visual analogue scale; PCA – bad demand – number of attempts to launch PCA during lockout; PCA – patient controlled analgesia.